Cannabis
Medical Marijuana, Inc. Subsidiary Kannaway® Expands International Leadership Team with Peter Dale as General Manager of Japan Division
Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that its subsidiary Kannaway® has appointed Peter Dale as General Manager of its Japan division slated to officially launch later this year.
Cannabidiol (CBD) products have been legal on a federal level in Japan since 2016, and have been available for retail purchase. According to a recent report from cannabis data provider Prohibition Partners, Asia’s CBD market is expected to reach $5.8 billion USD by 2024. The report also stated that China and Japan represent Asia’s two largest-value CBD markets with Japan representing around $800 million USD and China with almost $4.4 billion USD by 2024 – collectively accounting for about 90% share of the market.
Dale brings more than 40 years of consistently proven leadership experience at large corporations such as Nerium International, Javita Japan, Waiora, LLC, Nature’s Sunshine Products, and Natural Health Trends, Inc. Before joining Kannaway®, Dale was the Executive Manager of BUMP GK, a full-service market entry consulting agency, where he helped multi-national businesses navigate Japanese compliance regulations and utilize marketing resources to analyze the cost and rewards of the Japan market.
“Kannaway is proud to welcome Peter to the team as we continue our international expansion into Japan,” said Kannaway® CEO Blake Schroeder. “Dale has successfully led other organizations as they entered the Japanese marketplace and we are confident in his ability to make Kannaway Japan a major success.”
Dale will use his strong understanding of international management, sales and marketing, operations, and market development to help Kannaway® build out its operations in Japan and find the most efficient and effective way to bring CBD products to Japanese consumers.
“It humbles me to join the leadership team of this internationally respected company and I am confident that my marketing and operational expertise will help me lead Kannaway to expedited success in Japan,” said Kannaway® Japan General Manager Peter Dale. “I can see the great potential for CBD in Japan and I’m looking forward to helping Kannaway becoming the market leader for CBD here.”
To learn more about Kannaway®, please visit https://kannaway.com/.
SOURCE Medical Marijuana, Inc.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
Cannabis6 days ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®1 week ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan3 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf3 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care